Rationality of Tuberculosis Treatment for Drug-Susceptible Pulmonary Tuberculosis at a Primary Care in Bandung

Tuberculosis (TB) remains a significant global health concern, particularly in Indonesia. Ensuring rational TB treatment is crucial for effective disease control and preventing the emergence of drug resistance. This study aimed to evaluate the rationality of TB treatment among newly diagnosed drug-...

Full description

Saved in:
Bibliographic Details
Main Authors: Alfi Nurul Islamiyah, Syarifuddin Syarifuddin, Morsalina Akhsa, Iis Rukmawati, Eni Margayani, Linda Purnamawati Suherman, Vina Septiani, Robby Ramdani
Format: Article
Language:English
Published: Institute for Researches and Community Services Universitas Muhammadiyah Palangkaraya 2024-11-01
Series:Borneo Journal of Pharmacy
Subjects:
Online Access:https://journal.umpr.ac.id/index.php/bjop/article/view/5896
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841554858544463872
author Alfi Nurul Islamiyah
Syarifuddin Syarifuddin
Morsalina Akhsa
Iis Rukmawati
Eni Margayani
Linda Purnamawati Suherman
Vina Septiani
Robby Ramdani
author_facet Alfi Nurul Islamiyah
Syarifuddin Syarifuddin
Morsalina Akhsa
Iis Rukmawati
Eni Margayani
Linda Purnamawati Suherman
Vina Septiani
Robby Ramdani
author_sort Alfi Nurul Islamiyah
collection DOAJ
description Tuberculosis (TB) remains a significant global health concern, particularly in Indonesia. Ensuring rational TB treatment is crucial for effective disease control and preventing the emergence of drug resistance. This study aimed to evaluate the rationality of TB treatment among newly diagnosed drug-susceptible pulmonary TB patients in a primary care center in Bandung. A descriptive-analytical study was conducted on 56 patients who met the inclusion and exclusion criteria. Treatment rationality was assessed based on the Indonesian Society of Respirology 2021 and the National Guidelines for Medical Services 2020. While 100% of patients received the correct medication for the right indication and dose, the duration of therapy was suboptimal for most patients (83.93%) due to drug unavailability. This resulted in a lower-than-ideal treatment regimen, potentially compromising treatment outcomes and increasing the risk of drug resistance. These findings highlight the need for improved drug supply management and adherence to treatment guidelines to optimize TB treatment outcomes and reduce the burden of TB in Indonesia.
format Article
id doaj-art-4bbc4e1f89204ac890e96ff69d5d1f5d
institution Kabale University
issn 2621-4814
language English
publishDate 2024-11-01
publisher Institute for Researches and Community Services Universitas Muhammadiyah Palangkaraya
record_format Article
series Borneo Journal of Pharmacy
spelling doaj-art-4bbc4e1f89204ac890e96ff69d5d1f5d2025-01-08T08:42:13ZengInstitute for Researches and Community Services Universitas Muhammadiyah PalangkarayaBorneo Journal of Pharmacy2621-48142024-11-017410.33084/bjop.v7i4.5896Rationality of Tuberculosis Treatment for Drug-Susceptible Pulmonary Tuberculosis at a Primary Care in BandungAlfi Nurul Islamiyah0Syarifuddin Syarifuddin1Morsalina Akhsa2Iis Rukmawati3Eni Margayani4Linda Purnamawati Suherman5Vina Septiani6Robby Ramdani7Universitas Jenderal Achmad YaniUniversitas Jenderal Achmad YaniUniversitas Jenderal Achmad YaniIbrahim Adjie Primary CareUniversitas Jenderal Achmad YaniUniversitas Jenderal Achmad YaniUniversitas Jenderal Achmad YaniUniversitas Jenderal Achmad Yani Tuberculosis (TB) remains a significant global health concern, particularly in Indonesia. Ensuring rational TB treatment is crucial for effective disease control and preventing the emergence of drug resistance. This study aimed to evaluate the rationality of TB treatment among newly diagnosed drug-susceptible pulmonary TB patients in a primary care center in Bandung. A descriptive-analytical study was conducted on 56 patients who met the inclusion and exclusion criteria. Treatment rationality was assessed based on the Indonesian Society of Respirology 2021 and the National Guidelines for Medical Services 2020. While 100% of patients received the correct medication for the right indication and dose, the duration of therapy was suboptimal for most patients (83.93%) due to drug unavailability. This resulted in a lower-than-ideal treatment regimen, potentially compromising treatment outcomes and increasing the risk of drug resistance. These findings highlight the need for improved drug supply management and adherence to treatment guidelines to optimize TB treatment outcomes and reduce the burden of TB in Indonesia. https://journal.umpr.ac.id/index.php/bjop/article/view/5896Drug use evaluationRetrospective evaluationPulmonary tuberculosisPrimary care
spellingShingle Alfi Nurul Islamiyah
Syarifuddin Syarifuddin
Morsalina Akhsa
Iis Rukmawati
Eni Margayani
Linda Purnamawati Suherman
Vina Septiani
Robby Ramdani
Rationality of Tuberculosis Treatment for Drug-Susceptible Pulmonary Tuberculosis at a Primary Care in Bandung
Borneo Journal of Pharmacy
Drug use evaluation
Retrospective evaluation
Pulmonary tuberculosis
Primary care
title Rationality of Tuberculosis Treatment for Drug-Susceptible Pulmonary Tuberculosis at a Primary Care in Bandung
title_full Rationality of Tuberculosis Treatment for Drug-Susceptible Pulmonary Tuberculosis at a Primary Care in Bandung
title_fullStr Rationality of Tuberculosis Treatment for Drug-Susceptible Pulmonary Tuberculosis at a Primary Care in Bandung
title_full_unstemmed Rationality of Tuberculosis Treatment for Drug-Susceptible Pulmonary Tuberculosis at a Primary Care in Bandung
title_short Rationality of Tuberculosis Treatment for Drug-Susceptible Pulmonary Tuberculosis at a Primary Care in Bandung
title_sort rationality of tuberculosis treatment for drug susceptible pulmonary tuberculosis at a primary care in bandung
topic Drug use evaluation
Retrospective evaluation
Pulmonary tuberculosis
Primary care
url https://journal.umpr.ac.id/index.php/bjop/article/view/5896
work_keys_str_mv AT alfinurulislamiyah rationalityoftuberculosistreatmentfordrugsusceptiblepulmonarytuberculosisataprimarycareinbandung
AT syarifuddinsyarifuddin rationalityoftuberculosistreatmentfordrugsusceptiblepulmonarytuberculosisataprimarycareinbandung
AT morsalinaakhsa rationalityoftuberculosistreatmentfordrugsusceptiblepulmonarytuberculosisataprimarycareinbandung
AT iisrukmawati rationalityoftuberculosistreatmentfordrugsusceptiblepulmonarytuberculosisataprimarycareinbandung
AT enimargayani rationalityoftuberculosistreatmentfordrugsusceptiblepulmonarytuberculosisataprimarycareinbandung
AT lindapurnamawatisuherman rationalityoftuberculosistreatmentfordrugsusceptiblepulmonarytuberculosisataprimarycareinbandung
AT vinaseptiani rationalityoftuberculosistreatmentfordrugsusceptiblepulmonarytuberculosisataprimarycareinbandung
AT robbyramdani rationalityoftuberculosistreatmentfordrugsusceptiblepulmonarytuberculosisataprimarycareinbandung